Muhammad Adnan, et al. “RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE STUDIES OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) AND DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS EMPAGLIFLOZIN AND LINAGLIPTIN IN PHARMACEUTICAL DOSAGE FORM”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 5, May 2024, pp. 1697-09, https://doi.org/10.53555/jptcp.v31i5.6335.